Welcome to the board WinnipegPB. How about we wait and see what is in the upcoming Corporate Presentation on Monday February 11 at BIO CEO in NY for pipeline updates, any updates on the primate studies and other updates regarding the work on the xB3-001 program to prepare for the upcoming pre-IND meeting with the FDA. According to the latest January Corporate update, this meeting will occur in Q2 and during 2019 there will be Bioanalytical and Toxicology work on the xB3-001 program. They have shown a little primate data. See slide 7 from the January Corporate Update.

BearDownAZ